ApicHope Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
ApicHope Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 76%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.
Key information
76.0%
Debt to equity ratio
CN¥1.70b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥664.23m |
| Equity | CN¥2.23b |
| Total liabilities | CN¥2.34b |
| Total assets | CN¥4.57b |
Recent financial health updates
Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27
ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Recent updates
Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 38%
Oct 09Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year
May 27ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings
May 03Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates
May 02ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings
Feb 27Financial Position Analysis
Short Term Liabilities: 300723's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300723's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥870.7M).
Debt to Equity History and Analysis
Debt Level: 300723's net debt to equity ratio (46.3%) is considered high.
Reducing Debt: 300723's debt to equity ratio has increased from 6% to 76% over the past 5 years.
Debt Coverage: 300723's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 300723's interest payments on its debt are well covered by EBIT.